ELAN VS SWAV Stock Comparison

PerformanceAnalyst Price TargetsTechnicalsEarningsProfitVolatility
PerformanceAnalyst Price TargetsTechnicalsEarningsProfitVolatility

Performance

ELAN
10/100

ELAN returned -9.80% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

SWAV
10/100

SWAV returned -31.43% in the last 12 months. Based on SPY's performance of -12.52%, its performance is below average giving it a score of 10 of 100.

Analyst Price Targets

ELAN
64/100

11 analysts offer 12-month price targets for ELAN. Together, they have an average target of 27, the most optimistic target put ELAN at 37 within 12-months and the most pessimistic has ELAN at 18.

SWAV
10/100

1 analysts offer 12-month price targets for SWAV. Together, they have an average target of 238.4, the most optimistic target put SWAV at 338 within 12-months and the most pessimistic has SWAV at 175.

Technicals

ELAN
89/100

ELAN receives a 89 of 100 based on 14 indicators. 12 are bullish, 1 are bearish.

SWAV
25/100

SWAV receives a 25 of 100 based on 14 indicators. 3 are bullish, 10 are bearish.

Earnings

ELAN
100/100

ELAN has missed earnings 1 times in the last 20 quarters.

SWAV
13/100

SWAV has missed earnings 5 times in the last 20 quarters.

Profit

ELAN
22/100

Out of the last 20 quarters, ELAN has had 6 profitable quarters and has increased their profits year over year on 2 of them.

SWAV
51/100

Out of the last 20 quarters, SWAV has had 9 profitable quarters and has increased their profits year over year on 8 of them.

Volatility

ELAN
45/100

ELAN has had a lower than average amount of volatility over the last 12 months giving it a score of 44 of 100.

SWAV
50/100

SWAV has had an average amount of volatility over the last 12 months giving it a score of 50 of 100.

All score calculations are broken down here to help you make more informed investing decisions

Elanco Animal Health Incorporated Common Stock Summary

New York Stock Exchange / ELAN
Healthcare
Drug Manufacturers - Specialty & Generic
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Shockwave Medical, Inc. Common Stock Summary

Nasdaq / SWAV
Healthcare
Medical - Devices
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.